Physician profile
Robert E Brockie
NPI 1669467445
$14,128.97
in general payments reported to CMS, 2019-2025
47 companies · $2,017 in 2025
The $2,017 reported for 2025 was more than what a typical Interventional Cardiology provider received nationally (typical 2025 total: $1,092).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,093 · 2020: $888 · 2021: $1,367 · 2022: $2,039 · 2023: $3,040 · 2024: $2,685 · 2025: $2,017.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $7,566 · Education: $121 · Debt Forgiveness: $55.76.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $7,565.64 |
| Education | $120.69 |
| Debt Forgiveness | $55.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $2,177.84 | 2019-2025 | Confirm Rx, Aveir, Xience Skypoint |
| Janssen Pharmaceuticals, INC | $937.20 | 2019-2023 | Xarelto |
| Novartis Pharmaceuticals Corporation | $890.79 | 2019-2025 | |
| Pfizer INC. | $874.50 | 2019-2025 | |
| Merck Sharp & Dohme LLC | $868.71 | 2021-2025 | Verquvo, Capvaxive |
| Shockwave Medical, INC | $816.53 | 2022-2024 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter, Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Abiomed | $714.37 | 2019-2025 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $648.07 | 2019-2025 | Lifevest |
| Heartflow, INC. | $598.71 | 2022-2025 | |
| Amgen INC. | $590.67 | 2019-2025 | Repatha, Repatha |
| Edwards Lifesciences Corporation | $562.54 | 2022-2024 | Sapien 3 Ultra Resilia |
| Astrazeneca Pharmaceuticals Lp | $551.59 | 2019-2024 | Farxiga |
| E.R. Squibb & Sons, L.L.C. | $541.98 | 2019-2025 | Camzyos, Eliquis |
| Boston Scientific Corporation | $475.73 | 2019-2025 | Mamba, Watchman Flx, Watchman Access System |
| Medtronic, INC. | $460.58 | 2021-2025 | Symplicity G3, Resolute Onyx, Micra |
Show all 47 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Robert Brockie listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.